# AZSTARYS
> **NDA212994** · New Drug Application · Sponsor: COMMAVE THERAP · Approved 2021-03-02
## Drug
- **FDA Application Number:** NDA212994
- **Application type:** New Drug Application
- **Brand name:** AZSTARYS
- **Generic name:** SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE
- **Active ingredients:** DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** COMMAVE THERAP
- **Manufacturer:** Commave Sub, LLC
- **First approval:** 2021-03-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212994)
---
*AI Analytics · CC0 1.0*